FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns a pharmaceutical composition in the form of capsules, containing as active substances 3,31-diindolylmethane and epicatechin-3-gallate, and a method for making this composition. A method consists in mixing 3,31-diindolylmethane and epicatechin-3-gallate with a liquid fatty excipient and adding a wedding agent. In mixing, the prepared mixture is heated to 35-45°C to prepare a solution. Then the prepared solution is cooled to 22-25°C to fill gelatine capsules in the following proportions, g/capsule: 3,3'-diindolylmethane - 0.01-0.1, epicatechin-3-gallate - 0.02-0.04, liquid fatty excipient - 0.05-0.1, wedding agent - 0.4-0.45. The prepared drug in the form of soft gelatine capsules containing 3,31-diindolylmethane and epicatechin-3-gallate in the form of a solution, enables increasing bioavailability of the active substances.
EFFECT: prepared drug is non-toxic, safe in prolonged introduction, has no local irritant action, no toxic effect on the immune and reproductive systems.
5 cl, 6 ex, 7 tbl, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING GELATINE CAPSULES OF 3,3-DIINDOLYLMETHANE | 2011 |
|
RU2456987C1 |
DIINDOLYLMETHANE (DIM)-BASED MEDICATION WITH INCREASED BIOACCESSEBILITY AND ITS APPLICATION IN TREATMENT OF HUMAN HYPERPLASTIC AND INFLAMMATORY DISEASES | 2010 |
|
RU2419426C1 |
METHOD OF GREEN TEA EXTRACT PURIFICATION, BASED ON IT MEDICATION AND METHOD OF PREVENTION AND TREATMENT OF SKIN DISEASES | 2010 |
|
RU2437672C1 |
METHOD OF GREEN TEA EXTRACT PURIFICATION, BASED ON IT MEDICATION AND METHOD OF PREVENTION AND TREATMENT OF SKIN DISEASE | 2010 |
|
RU2437671C1 |
CONTROLLED-RELEASE PHARMACEUTICAL PROXODOLOL COMPOSITION | 2007 |
|
RU2356532C2 |
HEMOSTIMULANT AND PHARMACEUTICAL COMPOSITION AND METHOD FOR HEMOPOIESIS STIMULATION | 2011 |
|
RU2482869C1 |
PHARMACEUTICAL COMPOSITION OF PEDIPHENE FOR TREATING DAMAGE BY NON-LETHAL IRRITANTS | 2012 |
|
RU2496485C1 |
NOVEL CRYSTALLINE FORM OF N,N'-BIS-[2-(1N-IMIDAZOL-4-YL)ETHYL]PROPANEDIAMIDE AND PHARMACEUTICAL USE THEREOF | 2022 |
|
RU2823162C2 |
PHARMACEUTICAL FORMULATION IN SOLID DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2445091C1 |
METHOD FOR PRODUCING PHARMACEUTICAL EMULSION OF LACTULOSE | 2013 |
|
RU2555349C2 |
Authors
Dates
2012-04-27—Published
2011-03-21—Filed